Search

Search results

2106 results found

Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials.

Publication: Journal Article

Sephien, Andrew, Denisse Camille Dayto, Tea Reljic, Xavier Prida, Joanna M Joly, Matthew Tavares, Jason N Katz, and Ambuj Kumar. 2024. “Efficacy of Intravenous Iron in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials.”. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 24 (2): 285-302.

In silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ).

Publication: Journal Article

Kumar, Ambuj, Vidya Rajendran, Rao Sethumadhavan, and Rituraj Purohit. 2012. “In Silico Prediction of a Disease-Associated STIL Mutant and Its Affect on the Recruitment of Centromere Protein J (CENPJ).”. FEBS Open Bio 2: 285-93.

Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trials.

Publication: Journal Article

Miladinovic, Branko, Ambuj Kumar, Iztok Hozo, Helen Mahony, and Benjamin Djulbegovic. 2013. “Trial Sequential Analysis May Be Insufficient to Draw Firm Conclusions Regarding Statistically Significant Treatment Differences Using Observed Intervention Effects: A Case Study of Meta-Analyses of Multiple Myeloma Trials.”. Contemporary Clinical Trials 34 (2): 257-61.

Morgan Fuentes, AuD, CCC-A

Person: Clinical and Research Audiologist, Lab Manager

Dr. Laura Blair receives research grant from the Alzheimer's Association

News: July 22, 2022

New AARG funding from the Alzheimer's Association Dr. Laura Blair was awarded a 2022 Alzheimer's Association Research Grant. This funding will support the investigation of metabolic and autophagic changes in novel mouse models for neuropsychiatric symptoms in tauopathy.

Enim neque volutpat ac tincidunt vitae semper quis lectus

Blog: June 04, 2024

Mi proin sed libero enim sed faucibus. Sit amet est placerat in. Tellus molestie nunc non blandit. Turpis nunc eget lorem dolor sed viverra ipsum. Non pulvinar neque laoreet suspendisse interdum consectetur libero id. Optio vel quisquam nobis molestiae iste. Quia inventore est libero amet ea...

Mattis molestie a iaculis at erat pellentesque adipiscing

Blog: June 04, 2024

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mi sit amet mauris commodo quis imperdiet massa. Qui minus repellendus libero non rem perferendis. Consectetur magnam molestiae consequatur qui excepturi. Vero tenetur vel et...

An observation, longitudinal, prospective, long-team registry of patients with hypophosphatasia-Alexion HPP Registry ALX-HPP-501

News: June 05, 2020

An Observational, Longitudinal, Prospective, Long-Term Registry of Patients with hypophosphatasia ClinicalTrials.gov ID NCT02306720 Sponsor Alexion Pharmaceuticals, Inc. Information provided by Alexion Pharmaceuticals, Inc. (Responsible Party) Last Update Posted 2024-09-19 Study Overview In this...

A Non-Interventional Post-Authorization Safety Study (PASS) of Carbaglu® for the Treatment of Hyperammonemia Due to Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA) in Adult and Pediatric Patient Populations

News: June 02, 2020

A Non-Interventional Post-Authorization Safety Study (PASS) of Carbaglu® for the Treatment ofHyperammonemia Due to Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)in Adult and Pediatric Patient Populations ClinicalTrials.gov ID NCT05040178 Sponsor Recordati Rare Diseases Information provided...